News
-
-
-
-
-
-
-
PRESS RELEASE
HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
HBM Healthcare Investments announces Yellow Jersey Therapeutics acquisition by Johnson & Johnson for USD 1.25 billion. Transaction increases NAV per HBM share by CHF 8.70 (+3.5%) with expected cash inflow of USD 78 million -
-
-
PRESS RELEASE
HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
Swixx BioPharma, a portfolio company of HBM Healthcare Investments, expands into Latin America with acquisition of Laboratorios Biopas Group, boosting sales and profits